Simon de Bernard

Dr. Simon de Bernard

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2021 in Allergy
Verified
Journal Article
Closed access
PDF file
MLMarine‐Alexia Lefevre
Marine‐Alexia Lefevre
ANAudrey Nosbaum
Audrey Nosbaum
ARAurore Rozières
Aurore Rozières
VLVanina Lenief
Vanina Lenief
AMAmandine Mosnier
Amandine Mosnier
MVMarc Vocanson
Marc Vocanson

15 May 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MGMorgan Grau
Morgan Grau
SVSéverine Valsesia
Séverine Valsesia
JMJulien Mafille
Julien Mafille
SDSophia Djebali
Sophia Djebali
MTMartine Tomkowiak
Martine Tomkowiak
JMJacqueline Marvel
Jacqueline Marvel
The pool of memory-phenotype CD8 T cells is composed of Ag-induced (AI) and cytokine-induced innate (IN) cells. IN cells have been described as having properties similar to those of AI memory cells. However, we found that pathogen-induced AI memory cells can be distinguished in mice from naturally generated IN memory cells by surface expression of NKG2D. Using this marker, we described the increased functionalities of AI and IN memory CD8 T cells compared with naive cells, as shown by comprehensive analysis of cytokine secretion and gene expression. However, AI differed from IN memory CD8 T cells by their capacity to migrate to the lung parenchyma upon inflammation or infection, a process dependent on their expression of ITGA1/CD49a and ITGA4/CD49d integrins.

4 March 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
OBOlivia Bonduelle
Olivia Bonduelle
TDTristan Delory
Tristan Delory
IFIsabelle Franco-Moscardini
Isabelle Franco-Moscardini
MGMarion Ghidi
Marion Ghidi
SBSelma Bennacer
Selma Bennacer
CJcecile janssen
cecile janssen
BACKGROUND: The high-dose quadrivalent influenza vaccine (QIV-HD) showed superior efficacy against laboratory-confirmed illness compared with the standard-dose quadrivalent influenza vaccine (QIV-SD) in randomized controlled trials with the elderly. However, specific underlying mechanism remains unclear. METHODS: This phase IV randomized controlled trial compared early innate responses induced by QIV-HD and QIV-SD in 59 individuals aged > 65 years. Systemic innate cells and gene signatures at day 0 (D0) and D1 as well as hemagglutinin inhibition antibody (HIA) titers at D0 and D21 after vaccination were assessed. RESULTS: QIV-HD elicited robust humoral response with significantly higher antibody titers and seroconversion rates than QIV-SD. At D1 after vaccination, QIV-HD recipients showed significant reduction in innate cells, including conventional DCs and NK cells, compared with QIV-SD, correlating with significantly increased HIA titers at D21. Blood transcriptomic analysis revealed greater amplitude of gene expression in the QIV-HD arm, encompassing genes related to innate immune response, IFNs, and antigen processing and presentation, and correlated with humoral responses. Interestingly, comparative analysis with a literature dataset from young adults vaccinated with influenza standard-dose vaccine highlighted strong similarities in gene expression patterns and biological pathways with the elderly vaccinated with QIV-HD. CONCLUSION: QIV-HD induces higher HIA titers than QIV-SD, a youthful boost of the innate gene expression significantly associated with high HIA titers. TRIAL REGISTRATION: EudraCT no. 2021-004573-32.

19 February 2022 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
LSLinda Ljungberg Silic
Linda Ljungberg Silic
MLMarine‐Alexia Lefevre
Marine‐Alexia Lefevre
OBOla Bergendorff
Ola Bergendorff
SBSimon de Bernard
Simon de Bernard
JNJulien Nourikyan
Julien Nourikyan
MVMarc Vocanson
Marc Vocanson

1 May 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
SRSara Ribeiro
Sara Ribeiro
KAKarine Alves
Karine Alves
JNJulien Nourikyan
Julien Nourikyan
JLJean-Pierre Lavergne
Jean-Pierre Lavergne
SBSimon de Bernard
Simon de Bernard
LBLaurent Buffat
Laurent Buffat
Introduction: The global rise in antibiotic resistance and emergence of new bacterial pathogens pose a significant threat to public health. Novel approaches to uncover potential novel diagnostic and therapeutic targets for these pathogens are needed.Methods: In this study, we conducted a large-scale, phylogenetic-based orthology analysis (OA) to compare the proteomes of pathogenic to humans (HP) and non-pathogenic to humans (NHP) bacterial strains across 734 strains from 514 species and 91 families.Results: Using a dedicated workflow, we identified 4,383 hierarchical orthologous groups (HOGs) significantly associated with the HP label, many of which are linked to critical factors such as stress tolerance, metabolic versatility, and antibiotic resistance. Both known virulence factors (VFs) and potential novel widespread pathogenicity determinants were uncovered, supported by both statistical testing and complementary protein domain analysis.Discussion: By integrating curated strain-level pathogenicity annotations from BacSPaD with phylogeny-based OA, we introduce a novel approach and provide a novel resource for bacterial pathogenicity research.

9 August 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
SRSara Ribeiro
Sara Ribeiro
GCGuillaume Chaumet
Guillaume Chaumet
KAKarine Alves
Karine Alves
JNJulien Nourikyan
Julien Nourikyan
LSLei Shi
Lei Shi
BLBuffat Laurent
Buffat Laurent
The vast array of omics data in microbiology presents significant opportunities for studying bacterial pathogenesis and creating computational tools for predicting pathogenic potential. However, the field lacks a comprehensive, curated resource that catalogs bacterial strains and their ability to cause human infections. Current methods for identifying pathogenicity determinants often introduce biases and miss critical aspects of bacterial pathogenesis. In response to this gap, we introduce BacSPaD (Bacterial Strains’ Pathogenicity Database), a thoroughly curated database focusing on pathogenicity annotations for a wide range of high-quality, complete bacterial genomes. Our rule-based annotation workflow combines metadata from trusted sources with automated keyword matching, extensive manual curation, and detailed literature review. Our analysis classified 5502 genomes as pathogenic to humans (HP) and 490 as non-pathogenic to humans (NHP), encompassing 532 species, 193 genera, and 96 families. Statistical analysis demonstrated a significant but moderate correlation between virulence factors and HP classification, highlighting the complexity of bacterial pathogenicity and the need for ongoing research. This resource is poised to enhance our understanding of bacterial pathogenicity mechanisms and aid in the development of predictive models. To improve accessibility and provide key visualization statistics, we developed a user-friendly web interface.